Instructions
for Authors
Online Manuscript Submission: An online
submission and tracking service via Internet facilitates
a speedy and cost-effective submission of manuscripts.
The full manuscript has to be submitted online
via Bentham's Journal Management System (JMS) at
http://bsp-cms.eurekaselect.com
View
Instructions
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, provide soft copies of all the
materials (main text in MS Word or Tex/LaTeX), figures/illustrations
in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw
(CDX)/ISISDraw (TGF) as separate files, while a PDF version
of the entire manuscript must also be included, embedded with
all the figures/illustrations/tables/chemical structures etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables, references and images, to
ensure that they appear in proper format.
References, figures, tables, chemical structures etc.
should be referred to in the text at the appropriate place
where they have been first discussed. Figure legends/captions
should also be provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to humaira@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal publishes peer-reviewed
mini- and full-length review articles, research papers, and
drug clinical trial studies written in English. Single topic/thematic
issues may also be considered for publication.
Single Topic Issues: These peer-reviewed
issues may either contain invited or uninvited review/mini-review
articles or a mixture of research articles, letters, reviews/
mini-reviews and drug clinical trial studies. A Single Topic
Issue Editor will offer a short perspective and co-ordinate
the solicitation of manuscripts between 3-5 (for a mini-hot
topic) to 6-10 (for full-length hot topic) from leading scientists.
Authors interested in editing a single topic issue in an emerging
topic of medicinal chemistry and rational drug design for
the discovery of new central nervous system agents may submit
their proposal to the Editor-in-Chief at cmccnsa@benthamscience.org
for consideration.
MANUSCRIPT LENGTH:
Review Articles: The total number of words
for a published comprehensive review article article is from
8000 to 40000 words, and for mini-review articles from 3000
to 6000 words.
Research Articles: The total number of words for
a published research article is from 4000 to 8000 words.
Randomized Drug Clinical Trial Studies: Trial
studies should be 1500 to 40000 words excluding figures, structures,
photographs, schemes, tables etc.
There is no restriction on the number of figures, tables or
additional files e.g. video clips, animation and datasets,
that can be included with each article online. Authors should
include all relevant supporting data with each article (Refer
to Supplementary Material section.
Drug Clinical Trial Studies: Drug clinical
trial studies are biomedical or health-related interventional
and/or observational research studies conducted in phases
in human beings that follow a pre-defined protocol. The study
is intended to find out whether promising approaches to the
disease prevention, diagnosis, and treatment are safe and
effective. The maximum total page length for a drug clinical
trial study published in the journal is four journal pages.
Each journal page is on average 900 words.
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts may be
divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Appendices
Figures/illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/supplementary material (if any)
Covering Letter: It is mandatory that a signed covering
letter also be submitted along with the manuscript by the
author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
contains no such material or information that may be unlawful,
defamatory, fabricated, plagiarized, or which would, if published,
in any way whatsoever, violate the terms and conditions as
laid down in the copyright agreement. The authors acknowledge
that the publishers have the legal right to take appropriate
action against the authors for any such violation of the terms
and conditions as laid down in the copy right agreement. DOWNLOAD
COVERING LETTER
Title: The
title of the article should be precise and brief and must
not be more than 120 characters. Authors should avoid the
use of non-standard abbreviations. The title must be written
in title case except for articles, conjunctions and prepositions.
Authors should also provide a short ‘running title’.
Title, running title, byline, correspondent footnote and keywords
should be written as presented in original manuscripts.
Title Page: Title page should include paper title,
author(s) full name and affiliation, corresponding author(s)
names complete affiliation/address, along with phone, fax
and email.
Abstract: The abstract should not exceed 250 words
for review and research papers, and 150 words for drug clinical
trial studies summarizing the essential features of the article.
Keywords: Provide 6 to 8 keywords in alphabetical
order.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement, List of Abbreviations, Conflict of
Interest (if any) and Reference sections. For Research Articles
the manuscript should begin with the title page and abstract
followed by the main text, which must be structured into separate
sections as Introduction, Materials and Methods, Results,
Discussion, and Conclusion, Acknowledgements, List of Abbreviations,
Conflict of Interest (if any) and References. If your research
article reports the results of a controlled health care intervention
such as a Drug Clinical Trial Studies/Case Report, list your
trial registry, along with the unique identifying number.
The Review Article should mention any previous important recent
and old reviews in the field and contain a comprehensive discussion
starting with the general background of the field. It should
then go on to discuss the salient features of recent developments.
The authors should avoid presenting material which has already
been published in a previous review.
The authors are advised to present and discuss their observations
in brief. The manuscript style must be uniform throughout
the text and 10 pt Times New Roman fonts should be used. The
full term for an abbreviation should precede its first appearance
in the text unless it is a standard unit of measurement. The
reference numbers should be given in square brackets in the
text. Italics should be used for Binomial names of organisms
(Genus and Species), for emphasis and for unfamiliar words
or phrases. Non-assimilated words from Latin or other languages
should also be italicized e.g. in vivo, in vitro, per
se, et al. etc.
Authentication of Cell Lines: The NIH acknowledges
the misidentification and/or cross-contamination of cell cultures
e.g. HeLa cells being used in a research study as a serious
problem. In order to ensure the validation of the work and
proper utilization of resources, it is a prerequisite that
correct reagents be used in studies dealing with established
human (tumor) cell lines that have been cultured for more
than 4 years up to the date of submission of the manuscript.
Cell lines such as short-term cultures of human tumors, murine
cell lines (as a catalog of DNA profiles is not yet available)
and tumor cell lines established in the course of the study
that is being submitted, are presently exempt from this rule.
To minimize the risk of working with misidentified and/or
contaminated cell lines, tests such as isoenzyme analysis,
karyotyping/cytogenetic analysis and, more recently, molecular
techniques of DNA profiling may be carried out to authenticate
cell cultures. These tests may help confirm or establish the
identify profile for a cell line. Bentham Science recommends
that all cell lines be authenticated prior to submitting a
paper for review. Authors are therefore required to provide
authentication of the origin and identity of the cells by
performing cell profiling either in their own laboratory or
by outsourcing an approved laboratory or cell bank. Authentication
is required when a new line is established or acquired , before
freezing a cell line, if the performance of the line is not
consistent or results are unexpected, if using more than one
cell line, and before publication of the study.
The cell lines profile should be cross-checked with
the profile of the donor tissue of other continuous cell lines
such as provided by the authentic data bank such as http://www.dsmz.de/fp/cgi-bin/str.html,
ATCC® etc.
Trial registration: There should be no space
between the letters and numbers of your trial registration
number. All drug clinical trial studies, regardless of when
they were completed, and secondary analyses of original drug
clinical trial studies must be registered before submission
of a manuscript based on the trial. Studies designed for other
purposes, such as to study pharmacokinetics or major toxicity
(e.g., phase 1 trials), are exempt. Trial registry name, registration
identification number, and the URL for the registry should
be included at the end of abstract and also in the space provided
on the online manuscript submission form.
Authors will submit the Trial Protocols along with their manuscript.
The CONSORT (Consolidated Standards of Reporting Trials)
Checklist
and Flowchart is also required when submitting
the results of randomized control trials (RCTs).
Ethical Approval of Studies and Informed Consent:
For human or animal experimental investigations, it is a prerequisite
to provide a formal review and approval, or review and waiver,
by an appropriate institutional review board or ethics committee
and should be documented in your paper. For investigations
undertaken on human subjects, state in the Methods section
the manner in which the informed consent was obtained from
the study participants (i.e., oral or written), where there
is an unavoidable risk of breach of privacy e.g., in a clinical
photograph or in case details- the patient’s written
consent or that of the next of kin, to publication must be
obtained. We will ask you to send a signed consent form before
publication. Consent must be obtained for all Case Reports
and Drug Clinical Trial Studies.
Protection of Human Subjects
and Animals in Research: When
reporting experiments involving human subjects, authors should
indicate whether the procedures followed were in accordance
with the ethical standards of the responsible committee on
human experimentation (institutional and national) and with
the Helsinki Declaration of 1975, as revised in 2000.
For research involving animals, authors should indicate whether
the procedures followed were in accordance with the standards
set forth in the Guide for the Care and Use of Laboratory
Animals (published by the National Academy of Science, National
Academy Press, Washington, D.C).
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting
changes and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they
will be lost during conversion to PDF/XML.
Authors are encouraged to consult reporting guidelines. These
guidelines provide a set of recommendations comprising a list
of items relevant to their specific research design. Chemical
equations, chemical names, mathematical usage, unit of measurements,
chemical and physical quantity & units must conform to
SI and Chemical Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations are
used in the text either they should be defined in the text
where first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions to
the work being reported should be clearly acknowledged, as
should any potential conflict of interest.
Acknowledgements: Please acknowledge anyone (individual/company/institution)
who has contributed to the study by making substantial contributions
to conception, design, acquisition of data, or analysis and
interpretation of data, or who was involved in drafting the
manuscript or revising it critically for important intellectual
content. Please list the source(s) of funding for the study,
for each author, and for the manuscript preparation in the
acknowledgements section.
This journal complies with the International Committee of
Medical Journal Editors' Uniform Requirements for Manuscripts
Submitted to Biomedical Journals http://www.icmje.org
and the FDA's Good Reprint Practices for the Distribution
of Medical Journal Articles and Medical or Scientific Reference
Publications on Unapproved New Uses of Approved Drugs and
Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html
References: References must be listed in
the ACS Style only. All references should be numbered sequentially
[in square brackets] in the text and listed in the same numerical
order in the reference section. The reference numbers must
be finalized and the bibliography must be fully formatted
before submission.
See below few examples of references listed in the ACS Style:
Journal Reference:
[1] Bard, M.; Woods, R.A.; Bartón, D.H.; Corrie, J.E.;
Widdowson, D.A. Sterol mutants of Saccharomyces cerevisiae:
chromatographic analyses. Lipids, 1977,
12(8), 645-654.
[2] Zhang, W.; Brombosz, S.M.; Mendoza, J.L.; Moore, J.S.
A high-yield, one-step synthesis of o-phenylene ethynylene
cyclic trimer via precipitation-driven alkyne metathesis.
J. Org. Chem., 2005, 70,
10198-10201.
Book Reference:
[3] Crabtree, R.H. The Organometallic Chemistry of the
Transition Metals, 3rd
ed.; Wiley & Sons: New York, 2001.
Book Chapter Reference:
[4] Wheeler, D.M.S.; Wheeler, M.M. In: Studies in Natural
Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier Science
B. V: Amsterdam, 1994; Vol. 14,
pp. 3-46.
Conference Proceedings:
[5] Jakeman, D.L.; Withers, S.G.E. In: Carbohydrate Bioengineering:
Interdisciplinary Approaches, Proceedings of the 4th
Carbohydrate Bioengineering Meeting, Stockholm, Sweden, June
10-13, 2001; Teeri, T.T.; Svensson, B.; Gilbert, H.J.; Feizi,
T., Eds.; Royal Society of Chemistry: Cambridge, UK, 2002;
pp. 3-8.
URL (WebPage):
[6] National Library of Medicine. Specialized Information
Services: Toxicology and Environmental Health. http://sis.nlm.nih.gov/Tox/ToxMain.html
(Accessed May 23, 2004).
Patent:
[7] Hoch, J.A.; Huang, S. Screening methods for the identification
of novel antibiotics. U.S. Patent 6,043,045, March 28, 2000.
Thesis:
[8] Mackel, H. Capturing the Spectra of Silicon Solar
Cells. PhD Thesis, The Australian National University:
Canberra, December 2004.
E-citations:
[9] Citations for articles/material published exclusively
online or in open access (free-to-view) , must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
• All references must be complete and accurate.
• All authors must be cited and there should be no use
of the phrase et al.
• Online citations should include the date of access.
• Journal abbreviations should follow the Index
Medicus/MEDLINE.
• Take special care of the punctuation convention as
described in the above-mentioned examples.
• Superscript in the in-text citations and reference
section should be avoided.
• Abstracts, unpublished data and personal communications
(which can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
• The authors are encouraged to use a recent version
of EndNote (version 5 and above) or Reference Manager (version
10) when formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, use appendices,
which can be a part of the article. An appendix must not exceed
three pages (Times New Roman, 12 point fonts, 900 max. words
per page).The information should be provided in a condensed
form, ruling out the need of full sentences. A single appendix
should be titled APPENDIX, while more than one can be titled
APPENDIX A, APPENDIX B, and so on.
Figures/Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Central
Nervous System Agents in Medicinal Chemistry.
If the figures are found to be sub-standard, then the manuscripts
will be rejected/ and the authors offered the option of figure
improvement professionally by Bentham Publishing
Services. The costs for such improvement will
be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution:
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with color mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous tone
photograph and contains no text, the preferred file format
is TIFF, with color mode being or RGB or Grayscale, in a resolution
of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with color mode being or RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats:
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISISDraw)
Bentham Science does not process figures submitted in GIF
format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format, however in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include GraphicConverter
on the Macintosh, PaintShop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
• The cost for the first published page of color figures
is US$ 940; the second additional page will
be for US$ 685 and each subsequent page for
US$ 465.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures:
Chemical structures MUST be prepared in ChemDraw (CDX file)
and provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18% of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width
2.0 pt (0.071cm, 0.0278in)
Line width 0.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt
(0.096cm)
Hash spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font
Times New Roman
Size
8 pt
Under the Preference Choose:
Units
points
Tolerances 3
pixels
Under Page Setup Use:
Paper
US letter
Scale
100%
Tables:
• Data Tables should be submitted in Microsoft Word
table format.
• Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
• Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
• Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
• Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
• Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
• If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
• Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
Supportive/Supplementary Material: We do
encourage to append supportive material, for example a PowerPoint
file containing a talk about the study, a PowerPoint file
containing additional screenshots, a Word, RTF, or PDF document
showing the original instrument(s) used, a video, or the original
data (SAS/SPSS files, Excel files, Access Db files etc.)
provided it is inevitable or endorsed by the journal's Editor.
Supportive / Supplementary material intended for publication
must be numbered and referred to in the manuscript but should
not be a part of the submitted paper. In-text citations as
well as a section with the heading "Supportive / Supplementary
Material" before the "References" section should
be provided. Here, list all Supportive / Supplementary Material
and include a brief caption line for each file describing
its contents.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only on our Web
site. Please also make sure that each additional file is a
single table, figure or movie (please do not upload linked
worksheets or PDF files larger than one sheet). Supportive/
Supplementary material must be provided in a single zipped
file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication
but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced
material should not be included unless you have obtained written
permission from the copyright holder, which should be forwarded
to the Editorial Office in case of acceptance of your article
for publication.
For obtaining permission for reproducing any material published
in an article by Bentham Science Publishers, please fill in
the request FORM
and send to cmccnsa@benthamscience.org
for consideration.
AUTHORS AND INSTITUTIONAL AFFILIATIONS: The
author will be required to provide their full names, the institutional
affiliations and the location, with an asterisk in front of
the name of the principal/corresponding author. The corresponding
author(s) should be designated and their complete address,
business telephone and fax numbers and e-mail address must
be stated to receive correspondence and galley proofs.
PAGE CHARGES: No page charges will be levied
to authors for the publication of their article.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Manuscripts which are accepted for publication on condition
that the written English submitted is corrected, will be sent
a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
PROOF CORRECTIONS: Authors will receive page
proofs of their accepted paper before publications. To avoid
delays in publication, proofs should be checked immediately
for typographical errors and returned within 48 hours.
Major changes are not acceptable at the proof stage. If unable
to send corrections within 48 hours due to
some reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding)
author will receive electronically five free reprints. Reprints
may be ordered from the Publisher prior to publication of
the article. First named authors may also order a personal
print and online subscription of the journal at 50% off the
normal subscription rate by contacting the subscription department
at e-mail: subscriptions@benthamscience.org.
OPEN ACCESS PLUS: Accepted articles can be
published online for free open access for all to view, and
be deposited by the Publishers in PubMed Central. Open access
publishing provides the maximum dissemination of the article
to the largest audience. Authors must pay for this service.
All corresponding authors will be asked to indicate whether
or not they wish to pay to have their paper made freely available
on publication. If authors do not select the Open Access option,
then their article will be published with standard subscription-based
access at no charge.
Bentham Science offers authors the choice of open access
publication of their articles at a fee of US$ 2,200
per published article which allows indefinite free-to-view
online publication with Bentham Science.
For more information please contact us at e-mail: openaccess@benthamscience.org.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected to editorial scrutiny, usually in consultation with members of the journal Editorial Advisory Board and outside independent reviewers. Every effort will be made to peer review submitted papers quickly. Papers which are delayed by authors in revision for more than 30 days will have to be re-submitted as a new submission. Papers accepted for publication are typeset and proofs are dispatched to authors for any corrections prior to final publication.
COPYRIGHT: Authors who publish in Bentham
Science print & online journals will transfer copyright
to their work to Bentham Science Publishers. Submission of
a manuscript to the respective journals implies that all authors
have read and agreed to the content of the Covering Letter
or the Terms and Conditions. It is a condition of publication
that manuscripts submitted to this journal have not been published
and will not be simultaneously submitted or published elsewhere.
Plagiarism is strictly forbidden, and by submitting the article
for publication the authors agree that the publishers have
the legal right to take appropriate action against the authors,
if plagiarism or fabricated information is discovered. By
submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when
the article is accepted for publication. Once submitted to
the journal, the author will not withdraw their manuscript
at any stage prior to publication.
E-PUB AHEAD OF SCHEDULE: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub Ahead
of Schedule (http://www.benthamscience.com/cmccnsa/E-Pub-Ahead-of-Schedule.htm).
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors and authors
and their respective employees are not responsible or liable
for the use of any such inaccurate or misleading data, opinion
or information contained of articles in the E-Pub Ahead-of-Schedule.
|
